Literature DB >> 29454042

When Do You Start and When Do You Stop Screening for Colon Cancer in Inflammatory Bowel Disease?

Millie D Long1, Bruce E Sands2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29454042     DOI： 10.1016/j.cgh.2018.02.011

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  4 in total

1.  Silk fibroin-based nanotherapeutics: application in the treatment of colonic diseases.

Authors:  Shuangquan Gou; Yamei Huang; Junsik Sung; Bo Xiao; Didier Merlin
Journal:  Nanomedicine (Lond)       Date:  2019-07-10       Impact factor: 5.307

Review 2.  Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape.

Authors:  Elyse A Linson; Stephen B Hanauer
Journal:  Curr Gastroenterol Rep       Date:  2021-08-02

3.  Differential expression of tumor-associated genes and altered gut microbiome with decreased Akkermansia muciniphila confer a tumor-preventive microenvironment in intestinal epithelial Pten-deficient mice.

Authors:  Cody Howe; Su Jin Kim; Jonathon Mitchell; Eunok Im; Yong Sung Kim; You Sun Kim; Sang Hoon Rhee
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-10-04       Impact factor: 5.187

Review 4.  Health Maintenance for Adult Patients with Inflammatory Bowel Disease.

Authors:  Jana G Hashash; Michael F Picco; Francis A Farraye
Journal:  Curr Treat Options Gastroenterol       Date:  2021-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.